La chaîne d'options affiche les données clés des options sur actions de WK Kellogg à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour WK Kellogg..

WK Kellogg (NYSE:KLG) Stock, Chaîne d'Options

WK Kellogg

WK Kellogg is the second-largest cereal manufacturer in North America. Its cereal brands include Special K, Frosted Flakes, Raisin Bran, Froot Loops, Frosted Mini Wheats, Kashi, Corn Flakes, Rice Krispies, Apple Jacks, and Bear Naked. The company was spun off from the former Kellogg business, now known as Kellanova, where the former firm's global snacks portfolio and international cereal brands are now housed. WK Kellogg, which began trading independently in October 2023, generates the bulk of its sales (about 88% of its fiscal 2023 base) from the US.

WK Kellogg Co

Kalo Gold Corp

KLEGG ELECTRONICS INC by Klegg Electronics, Inc.

Klegg Electronics Inc

KERRY LOGISTICS UNSP/ADR by Kerry Logistics Network Ltd

Kerry Logistics Network Ltd

Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) affirms FY2025 Product sales outlook from $450.00 million-475.00 million to $450.00 million-475.00 million.

News

Guidance

IOVA

Iovance Biotherapeutics Affirms FY2025 Product Sales Guidance from $450.00M-475.00M to $450.00M-475.00M

Collegium Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLL#NASDAQ">COLL</a>) raises FY2024 sales outlook from $580.00 million-595.00 million to $620.00 million-635.00 million.

COLL

Collegium Pharmaceutical Raises FY2024 Sales Guidance from $580.00M-595.00M to $620.00M-635.00M  VS Est.625.37M

CPAY

Corpay Expects Q4 Total Revenues Of $1.04B - $1.07B, Adjusted EP Of $5.25 - $5.45

Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) affirms FY2024 Product sales outlook from $160.00 million-165.00 million to $160.00 million-165.00 million.

Iovance Biotherapeutics Affirms FY2024 Product Sales Guidance from $160.00M-165.00M to $160.00M-165.00M

AerSale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASLE#NASDAQ">ASLE</a>) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $82.68 million which missed the analyst consensus estimate of $92.83 million by 10.93 percent. This is a 10.60 percent decrease over sales of $92.48 million the same period last year.

Earnings

Earnings Misses

ASLE

AerSale Q3 Adj $0.04 Misses $0.05 Estimate, Sales $82.68M Miss $92.83M Estimate

Amprius Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. The company reported quarterly sales of $7.855 million which beat the analyst consensus estimate of $4.215 million by 86.37 percent. This is a 180.74 percent increase over sales of $2.798 million the same period last year.

Earnings Beats

AMPX

Amprius Technologies Q3 2024 GAAP EPS $(0.10) Beats $(0.13) Estimate, Sales $7.855M Beat $4.215M Estimate

Identiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>) sees Q4 sales of $6.000 million-6.300 million vs $5.95 million estimate.

INVE

Identiv Sees Q4 Sales $6.000M-6.300M vs $5.95M Est

Fourth Quarter 2024 Outlook
For the fourth quarter 2024, the Company expects:
<ul>
<li>Revenue growth on a constant currency basis in the range of 10.3%-13.3%. This represents revenue in the range of $375-$385 million, assuming FX rates remain relatively stable with the end of Q3.&nbsp;</li>
<li>Adjusted EBITDA in the range of $9-$14 million, representing an Adjusted EBITDA Margin in the range of 2.4%-3.6%.&nbsp;</li>
</ul>

WBTN

WEBTOON Entertainment Sees Q4 Revenue Growth On A Constant Currency Basis In The Range Of 10.3%-13.3% ($375M-$385M) Vs $375.92M Est.

Tidewater Sees 2024 Revenue $1.33B-$1.35B vs $1.39B Est.

Innodata (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NASDAQ">INOD</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.13 by 169.23 percent. The company reported quarterly sales of $52.224 million which beat the analyst consensus estimate of $36.113 million by 44.61 percent. This is a 135.57 percent increase over sales of $22.169 million the same period last year.

INOD

Innodata Q3 2024 Adj. EPS $0.35 Beats $0.13 Estimate, Sales $52.224M Beat $36.113M Estimate

ABNB

Airbnb Sees Q4 2024 Revenue $2.39B-$2.44B Vs $3.717B Est.

Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.57) by 5.26 percent. This is a 39.33 percent increase over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $28.07 million which beat the analyst consensus estimate of $28.02 million by 0.20 percent. This is a 26.41 percent increase over sales of $22.21 million the same period last year.

OUST

Ouster Q3 EPS $(0.54) Beats $(0.57) Estimate, Sales $28.07M Beat $28.02M Estimate

AFRM

Affirm Sees FY25 GMV OF More Than $34B

Accelerate Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXDX#NASDAQ">AXDX</a>) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.47) by 25.53 percent. This is a 1083.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $2.975 million which missed the analyst consensus estimate of $3.020 million by 1.49 percent. This is a 9.82 percent decrease over sales of $3.299 million the same period last year.

AXDX

Accelerate Diagnostics Q3 2024 GAAP EPS $(0.59) Misses $(0.47) Estimate, Sales $2.975M Miss $3.020M Estimate

Financial Outlook for Full Year 2024
The following tables summarize Getty Images' updated fiscal year 2024 guidance:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Updated 2024 Guidance</td>
<td>Prior 2024 Guidance</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Revenue</td>
<td>$934 million to $943 million</td>
<td>$924 million to $943 million</td>
</tr>
<tr>
<td>Revenue YoY</td>
<td>1.9% to 2.9%</td>
<td>0.9% to 2.9%</td>
</tr>
<tr>
<td>Revenue YoY, Currency Neutral</td>
<td>1.6% to 2.6%</td>
<td>1.0% to 3.0%</td>
</tr>
<tr>
<td>Adjusted EBITDA</td>
<td>$292 million to $294 million</td>
<td>$290 million to $294 million</td>
</tr>
<tr>
<td>Adjusted EBITDA YoY</td>
<td>(3.1)% to (2.5)%</td>
<td>(3.8)% to (2.5)%</td>
</tr>
<tr>
<td>Adjusted EBITDA YoY, Currency Neutral</td>
<td>(3.4)% to (2.8)%</td>
<td>(3.6)% to (2.3)%</td>
</tr>
</tbody>
</table>
</figure>
 Guidance has been updated to reflect the Company's financial performance year to date and the impact of foreign currency exchange rates on both Revenue and Adjusted EBITDA.

GETY

Getty Images Raises FY24 Revenue From $924M-$943M To $934M-$943M Vs $932.61M Est.

Affirm Sees Q2 Revenue $770M-$810M

Corpay Narrows FY24 Total Revenue Outlook From $3.975B - $4.025B To $3.98B - $4.01B (Est $3.989B), Adjusted EPS Forecast From $18.85 - $19.15. To $18.90 - $19.10 (Est $18.96)

Upland Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) narrows FY2024 sales outlook from $269.60 million-281.60 million to $272.60 million-278.60 million.

UPLD

Upland Software Narrows FY2024 Sales Guidance from $269.60M-281.60M to $272.60M-278.60M  VS Est.274.57M

Vinci Partners Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $1.01 by 6.93 percent. The company reported quarterly sales of $112.716 million which beat the analyst consensus estimate of $110.552 million by 1.96 percent. This is a 414.00 percent increase over sales of $21.929 million the same period last year.

VINP

Vinci Partners Inv Q3 2024 Adj. EPS $1.08 Beats $1.01 Estimate, Sales $112.716M Beat $110.552M Estimate

Green Dot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDOT#NYSE">GDOT</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.17 by 23.53 percent. The company reported quarterly sales of $406.019 million which beat the analyst consensus estimate of $392.579 million by 3.42 percent. This is a 16.48 percent increase over sales of $348.571 million the same period last year.

GDOT

Green Dot Q3 2024 Adj. EPS $0.13 Misses $0.17 Estimate, Sales $406.019M Beat $392.579M Estimate

WK Kellogg Co May Be Worth More Than The Cereal It Sells

Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Beyond Meat (BYND – Research Report), Village Farms Internati...

Analysts Offer Insights on Consumer Goods Companies: Beyond Meat (BYND), Village Farms International (VFF) and WK Kellogg Co (KLG)

Cheez-It and Skittles! Kellanova soars as Mars confirms merger

Food spotlight: Blockbuster M&A as Mars takes Kellanova private, pantry inflation up 1%

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Privately held Mars is buying Kellanova (NYSE:<a href="https://investorplace.com/stock-quotes/k-stock-quote/">K</a>), the snacks division of cereal giant Kellogg&rsquo;s. The stock will be bought for <a href="https://www.cnn.com/2024/08/14/business/mars-buys-kellanova/index.html">$83.50 per share</a>. 



Before the announcement, K stock was selling for $74.50 per share. It was about $80 before the market opened today.



CNN said the all-cash deal was worth $29.5 billion, but&nbsp;The&nbsp;New York Times said it was <a href="https://www.nytimes.com/2024/08/14/business/dealbook/mars-kellanova-deal-pringles-cheezit.html">worth $35.9 billion</a>. The difference is mainly due to the $5 billion in <a href="https://s203.q4cdn.com/897568180/files/doc_financials/2024/q2/K-Q2-2024-RESULTS.pdf">long-term debt</a> Kellanova had on its balance sheet at the end of June.



<h2>Split and Sell</h2>



Something like this became likely last October when Kellogg&rsquo;s <a href="https://www.battlecreekenquirer.com/story/news/local/2023/10/02/kellogg-co-completes-split-into-two-independent-companies/71031756007/">breakup</a> became official. The remaining cereal business is called W.K. Kellogg (NYSE:<a href="https://investorplace.com/stock-quotes/klg-stock-quote/">KLG</a>), and has a market capitalization of about $1.4 billion. Kellanova shareholders were given one share of KLG for each Kellanova share they held, with the latter retaining the company&rsquo;s stock symbol of K.



Kellogg&rsquo;s believed investors weren&rsquo;t properly valuing the company, which is known for brands like Kellogg&rsquo;s Corn Flakes and Special K. The break, <a href="https://www.businessinsider.com/kelloggs-is-breaking-up-business-cereal-plant-snack-2022-6">announced in June 2022</a>, was designed to separate out faster-growing snack brands like Cheez-Its, Pringle&rsquo;s and Eggo. After the split, Kellanova maintained dual offices in Chicago and Kellogg&rsquo;s traditional home of Battle Creek, Michigan. Mars is based in McLean, Virginia.



Mars, best known for candy like M&amp;Ms and Snickers, has become a pet care giant in recent years. Last year, it received 20% of its revenue from pets, and its veterinary units&nbsp;<a href="https://www.pymnts.com/news/retail/2023/mars-ceo-aims-double-sales-investing-pets/" target="_blank">grew at 5-6%,</a>&nbsp;a faster rate than the candy business. Mars&rsquo;s veterinary units&nbsp;<a href="https://www.pymnts.com/news/retail/2023/mars-ceo-aims-double-sales-investing-pets/">include</a>&nbsp;Banfield Pet Hospitals and VCA Animal Hospitals, as well as veterinary chains in Europe and Singapore.



The best-known food brand in the Petcare portfolio may be Pedigree dog food, which suffered <a href="https://www.petfoodindustry.com/safety-quality/pet-food-recalls/article/15671180/mars-petcare-recalls-315-bags-of-pedigree-dog-food">a recall in May</a>. The unit <a href="https://www.mars.com/our-brands">also sells</a> Whiskas cat food and Royal Canin dog food.



<h2>K Stock: What Happens Next?</h2>



The deal should clear antitrust scrutiny easily since Kellanova sells salty snacks and Mars sweet snacks. It also balances out Mars&rsquo; growth in pet care.



On the date of publication, Dana Blankenhorn did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div><a href="http://www.danablankenhorn.com/">Dana Blankenhorn</a> has been a financial and technology journalist since 1978. He is the author of <a href="https://www.amazon.com/Technologys-Big-Bang-Yesterday-Tomorrow-ebook/dp/B0829C7XSF">Technology&rsquo;s Big Bang: Yesterday, Today and Tomorrow with Moore&rsquo;s Law</a>, available at the Amazon Kindle store. Tweet him at <a href="http://www.twitter.com/danablankenhorn">@danablankenhorn</a>, connect with him on <a href="https://journa.host/@DanaBlankenhorn"> Mastodon</a> or subscribe to his <a href="https://danafblankenhorn.substack.com/">Substack</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/mars-announces-kellanova-deal-what-this-means-for-k-stock/">Mars Announces Kellanova Deal: What This Means for K Stock</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Mars Announces Kellanova Deal: What This Means for K Stock

Wall Street Breakfast: What Moved Markets

BellRing Brands, Vital Farms, and General Mills shine in the latest Nielsen data

WK Kellogg Co (KLG) has disclosed a new risk, in the Corporate Activity and Growth category. WK Kellogg Co's recent fiscal quarter disclosures indi...

Kellogg's Latest Disclosure Reveals No New Insider Trading Plans: A Look at Transparency and Investor Implications

WK Kellogg declares $0.16 dividend

In a report released today, Andrew Lazar from Barclays assigned a Sell rating to WK Kellogg Co (KLG – Research Report), with a price target of $16....

Barclays Issues a Sell Rating on WK Kellogg Co (KLG)

AMZN

BRBR

BRFS

BYND

CELH

CHTR

DANOY

GOOGL

INGR

JJSF

LANC

MDLZ

MNST

NVDA

POST

SBUX

SMCI

SMPL

ULTA

VITL

YELP

Screenshot 2024-04-23 at 5.37.25 PM

Emerging Markets

Movers & Shakers

Markets

BRLS

Borealis Teams Up With Sam&#39;s Club, Feeding America To Fight Hunger, Food Insecurity In America

Dividends

Press Releases

WK Kellogg Co Declares Quarterly Dividend of $0.16 per Share

WK Kellogg Co Announces First Quarter Financial Results; Company Reaffirms 2024 Guidance

WK Kellogg Co to Participate in the 4th Annual Evercore ISI Consumer and Retail Conference on June 11, 2024

WK Kellogg Co to Host Conference Call on August 6

WK Kellogg Co Announces Second Quarter Financial Results and Next Steps of Supply Chain Modernization Plan

WK Kellogg Co to Participate in the Barclays 17th Annual Global Consumer Staples Conference on Wednesday, September 4, 2024

WK Kellogg Co to Host Conference Call on November 7

WK Kellogg Co Announces Third Quarter Financial Results and Raises 2024 Adjusted EBITDA Guidance

Forafric Global

Adecoagro

Mission Produce

B&G Foods

Beyond Meat

Cal-Maine Foods

Calavo Growers

Dole

Flowers Foods

The Hain Celestial Group, Inc. - Common Stock

Hain Celestial Group

John B. Sanfilippo & Son, Inc. - Common Stock

John B Sanfilippo & Son

J&J Snack Foods

Lancaster Colony Corporation - Common Stock

Lancaster Colony

Lifeway Foods

Mama`s Creations

Nomad Foods

Oatly Group AB - American Depositary Shares

Oatly Group

Seaboard

Seneca Foods Corp. - Class A Common Stock

Seneca Foods

The Simply Good Foods Company - Common Stock

Simply Good Foods

Treehouse Foods

Tootsie Roll Industries, Inc. Common Stock

Tootsie Roll Industries

Utz Brands

Vital Farms

Westrock Coffee

JP Morgan

Stifel

Barclays

B of A Securities

TD Cowen

WIIM

WK Kellogg shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results and raised its FY24 adjusted EBITDA guidance.

Comments

WK Kellogg

WK Kellogg (KLG) Options

WK Kellogg (NYSE:KLG) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL